Pharmaceutical Manufacturing

In 2022, the revenue of the pharmaceutical manufacturing segment by Fosun Pharma amounted to 30.812 billion, representing a YoY increase of 6.60%.

Fosun Pharma focuses on core therapeutic fields such as tumors (solid tumors and hematologic tumors), immunity, central nervous system, and chronic diseases (hepatopathy/metabolic diseases/nephropathy) through independent research and development, cooperative development, license-in, and in-depth incubation, emphasizes strengthening small molecules, antibodies/ADC, cell therapy, RNA and other core technical platforms, creates an open and global innovative R&D system, actively explores the technical distribution for RNA, TPD, AI-assisted therapy, etc., and persistently enhances core R&D capabilities and pipeline value, so as to promote the R&D and commercialization of more FIC (First-in-class) and BIC (Best-in-class) products.

By the end of 2022, the company had more than 260 projects for drugs under development, including innovator drugs, biosimilars, generic drugs, and those for consistency evaluation. In 2022, the company applied for 249 patents in the pharmaceutical manufacturing segment, including 16 US patents and 17 PCT applications, with 48 patents granted.

  • Major products of oncology and immunomodulation

    Major products of oncology and immunomodulation: Han Qu You (Trastuzumab for Injection), Han Li Kang (Rituximab Injection), Doptelet (Avatrombopag Maleate Tablets), Han Si Zhuang (Serplulimab Injection), Ke Sheng (Xihuang Capsules), Han Da Yuan (Adalimumab Injection), Kai Lai Zhi (Epinastine Hydrochloride Capsules), Zhao Hui Xian (Bicalutamide Tablets), Yi Luo Ze/Tu Mei Si (Pemetrexed Disodium for Injection), Akynzeo (Netupitant and Palonosetron Hydrochloride Capsules), Di Kai Mei (Sorafenib Tosylate Tablets), ondansetron, paclitaxel, and oxaliplatin.

  • Major products of metabolism and digestive System

    Major products of metabolism and digestive system: You Li Tong (Febuxostat Tablets), Atomolan (Glutathione Tablets), animal insulin and its preparations, Bei Yi (Potassium Chloride Granules), Ke Yi (New Compound Aloe Capsules), Atomolan (Reduced Glutathione for Injection), Yi Bao (Recombinant Human Erythropoietin for Injection (CHO Cells)), Li Qing (Alfacalcidol Tablets), Wan Su Ping (Glimepiride Tablets), Wan Su Jing (Empagliflozin Tablets), Fan Ke Jia (Lipoic Acid Injection), human insulin and its preparations.

  • Major products of anti-infection

    Major products of anti-infection: Comirnaty (mRNA COVID-19 Vaccine), Jie Bei An (Azvudine Tablets), antimalarial series such as artesunate, non-lyophilized rabies vaccine for human use (VERO Cell), Xi Chang/Bi Li Shu (Cefmetazole Sodium for Injection), Sha Duo Li Ka (Potassium Sodium Pehydroandroandrographolide Succinate for Injection), anti-tuberculosis series, Pai Shu Xi Lin (Piperacillin Sodium and Tazobactam Sodium for Injection), Meicelin (Cefminox Sodium for Injection), daptomycin, Qiang Shu Xi Lin/Qin Shu/Er Ye Qin (Piperacillin Sodium and Sulbactam Sodium for Injection), caspofungin, Heptodin (Lamivudine Tablets), Cravit (Levofloxacin Tablets, Levofloxacin Injection), micafungin, vancomycin, Er Ye Bi (Cefizoxime Sodium for Injection), Si Ke Ni (Azithromycin Capsules), Ka Di (Flucloxacillin Sodium for Injection), and Rui Sai Ning (Clindamycin Hydrochloride Capsules).

  • Major products of central nervous system

    Major products of central nervous system: Qi Wei (Quetiapine Fumarate Tablets), Qi Cheng (Escitalopram Oxalate Tablets), Chang Tuo Ning (Penehyclidine Hydrochloride Injection), Ao De Jin (Deproteinized Calf Blood Injection), and Lorazepam Tablets.

  • Major products of cardiovascular system

    Major products of cardiovascular system: Heparin preparations, Bang Tan (Telmisartan Tablets), Bang Zhi (Pitavastatin Calcium Tablets), Ya Ni An (Amlodipine Besylate Tablets), Ke Yuan (Calcium Dobesilate Capsules), You Di Er (Alprostadil Dried Emulsion for Injection), Xin Xian An (Meglumine Adenosine Cyclophosphate Injection), and Doptelet (Indapamide Tablets).

  • Major products of APIs and intermediates

    Major products of APIs and intermediates: Amino acid series, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride.

Member Companies

  • Shanghai Henlius Biotech, Inc.

  • Jiangsu Wanbang Biopharmaceuticals Co., Ltd.

  • YAOPHARMA CO., LTD.

  • Guilin Pharmaceutical Co., Ltd.

  • HONGQI PHARMACEUTICAL

  • Suzhou Erye Pharmaceutical Co., Ltd HOME

  • Avanc Pharmaceutical Co.,Ltd

  • Gland Pharma Limited

友情链接:太阳集团电子游戏  多宝体育  凯发官网入口  im体育app官方下载  鸿运国际  云顶国际  大奖国际  九游会官网平台  10bet十博体育  立博app